KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,000 | +214.3% | 3,989 | +179.7% | 0.00% | – |
| Q2 2022 | $7,000 | -70.8% | 1,426 | -55.8% | 0.00% | – |
| Q1 2022 | $24,000 | +33.3% | 3,229 | +17.1% | 0.00% | – |
| Q4 2021 | $18,000 | +38.5% | 2,758 | +30.6% | 0.00% | – |
| Q3 2021 | $13,000 | +8.3% | 2,112 | +80.4% | 0.00% | – |
| Q2 2021 | $12,000 | +500.0% | 1,171 | +561.6% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 177 | +22.9% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 144 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 144 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | -25.0% | 144 | -26.2% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 195 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 195 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -92.0% | 195 | -95.4% | 0.00% | – |
| Q2 2019 | $25,000 | +4.2% | 4,230 | +4.8% | 0.00% | – |
| Q1 2019 | $24,000 | +242.9% | 4,035 | +467.5% | 0.00% | – |
| Q4 2018 | $7,000 | -78.8% | 711 | +1.6% | 0.00% | – |
| Q2 2014 | $33,000 | +57.1% | 700 | +2.2% | 0.00% | – |
| Q1 2014 | $21,000 | -27.6% | 685 | -46.3% | 0.00% | – |
| Q4 2013 | $29,000 | – | 1,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |